Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Debt / NOTE 1.500% 6/1
-
Market price (% of par)
-
101.75%
-
Total 13F principal
-
$172,488,037
-
Principal change
-
-$18,648,713
-
Total reported market value
-
$168,248,167
-
Number of holders
-
24
-
Value change
-
-$19,039,698
-
Number of buys
-
7
-
Number of sells
-
6
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q3 2022
As of 30 Sep 2022,
IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 was held by
24 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$172,488,037
in principal (par value) of the bond.
The largest 10 bondholders included
CITADEL ADVISORS LLC, CAMDEN ASSET MANAGEMENT L P /CA, CAPSTONE INVESTMENT ADVISORS, LLC, WOLVERINE ASSET MANAGEMENT LLC, CALAMOS ADVISORS LLC, PUTNAM INVESTMENTS LLC, Polar Asset Management Partners Inc., SSI INVESTMENT MANAGEMENT LLC, AQR Arbitrage LLC, and SHENKMAN CAPITAL MANAGEMENT INC.
This page lists
25
institutional bondholders reporting positions
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.